References
- Dressman JB, Amidon GL, Reppas C, Shah V. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 1998;15:11–22.
- Swarbrick J. In vitro dissolution, drug bioavailability, and the spiral of science. Pharm Technol 1997;21:68–72.
- US Food and Drug Administration. Guidance for industry, dissolution testing of immediate release solid oral dosage forms. Rockville (MD): US Food and Drug Administration; 1997.
- US Food and Drug Administration. Guidance for industry, extended release solid oral dosage forms, development, evaluation and application of in vitro/in vivo correlations. Rockville (MD): US Food and Drug Administration; 1997.
- US Food and Drug Administration. Guidance for industry, SUPAC–MR modified release solid oral dosage forms, scale-up and post-approval changes: chemistry, manufacturing and controls, in vitro dissolution testing, and in vivo bioequivalence documentation. Rockville (MD): US Food and Drug Administration; 1997.
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Validation of Analytical Procedures. Text and Methodology Q2(R1); 2005.
- United States Pharmacopeia and National Formulary (USP-38-NF33), United States Pharmacopeia Convention, Rockville (2015) 711, Dissolution.
- Shah VP, Konecny JJ, Everett RL, et al. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm Res 1989;6:612–618.
- O’Hara T, Dunne A, Butler J, Devane J. A review of methods used to compare dissolution profile data. Pharm Sci Technol 1998;1:214–223.
- Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech 1996;20:64–74.
- Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–133.
- Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–49.
- Chow SC, Ki FY. Statistical comparison between dissolution profiles of drug products. J Biopharm Stat 1997;7:241–258.